May 27, 2025 10:31 AM EDT

ITM reveals up to $262M debt financing; Caris Life Sciences to go public

ENDPOINTS

Plus, news about Lexeo, TreeFrog Therapeutics, Hansa Biopharma, AbbVie, Elpiscience Biopharmaceuticals, Immutep, Hedera Dx, C4X Discovery, Sanofi, XOMA and BioInvent:

ITM Isotope Technologies Munich gets …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

ITM reveals up to $262M debt financing; Caris Life Sciences to go public

ENDPOINTS

Sign up to read this article for free.

VP, Clinical Development / CMO / CDO‬ ‭ (Stealth Portfolio Company)

Autonomy Bio Inc.

San Francisco, CA 94107, USA

A new dawn for psychedelics? Compass could be the first to find out

Weeks after TIGIT fail, iTeos decides to wind down

Updated: MD Anderson-allied investment firm targets $250M for second cancer biotech fund

Strand Therapeutics reports promising start for mRNA cancer therapy

GSK, Spero report Phase 3 win for UTI antibiotic; Spero's stock soars

From weeks to days: how Aizon Intelligent Agents transform pharma validation

ITM re­veals up to $262M debt fi­nanc­ing; Caris Life Sci­ences to go pub­lic

Sign up to read this article for free.

Autonomy Bio Inc.

San Francisco, CA 94107, USA

ITM reveals up to $262M debt financing; Caris Life Sciences to go public